Compare IONQ Inc (IONQ) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IONQ Inc vs uniQure N.V. Ordinary Shares — how do they compare? IONQ Inc trades at $31.07 (market cap $14.07B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: IONQ Inc is far larger — about 9.5× uniQure N.V. Ordinary Shares's market cap, and IONQ Inc is more actively traded (23,412,195 versus 2,488,780). Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 34 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| IONQ | QURE | |
|---|---|---|
Market Cap | $14.07B | $1.48B |
Volume | 23,412,195 | 2,488,780 |
Sector | Technology | Health |
52-Week High | $72.41 | $70.59 |
52-Week Low | $26.59 | $9.03 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $12.01B | $728.62M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $34.73, down 4.25% today, with a bearish technical signal despite recent earnings beats. The quantum computing company shows explosive revenue growth (2025: $130M, 2026: $246M) but faces significant profitability challenges with a -553% net income margin. Analyst consensus is split with a $65.20 price target suggesting 88% upside potential, while technical indicators show oversold conditions with RSI at 26.86.
The stock presents high-risk, high-reward potential with Wall Street divided on its path to profitability. Key catalysts include quantum technology adoption and manufacturing scaling, while risks center on cash burn and competitive threats in the emerging quantum computing space.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
